Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezepelumab in adults with severe uncontrolled asthma (China, Phase III)
CTR20181392Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of tezepelumab in asthma, sponsored by AstraZeneca. Started Jul 2019; status: completed.
02
Drugs
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20181392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181392.